OMMAX appoints Sandra Welchering as partner in Life Sciences & Healthcare practice

OMMAX appoints Sandra Welchering as partner in Life Sciences & Healthcare practice

11 September 2026 Consultancy.eu
OMMAX appoints Sandra Welchering as partner in Life Sciences & Healthcare practice

OMMAX, a digital strategy and AI consultancy, has hired former BCG partner Sandra Welchering as a senior leader in its Life Sciences & Healthcare practice.

Welchering brings more than 20 years of strategy consulting and industry experience. Before joining OMMAX, she spent three years as a partner at Boston Consulting Group, and prior to that, she spent seven years at McKinsey & Company. Earlier in her career, Welchering worked thirteen years in industry at Bayer, where she held strategic, financial and commercial roles in Germany and the United States.

In her role at OMMAX, Welchering will co-lead the Life Sciences & Healthcare practice alongside Anja Konhäuser (founding partner at OMMAX) and Lisa Marsfeld, taking particular responsibility for accelerating growth in international markets.

Founded in Germany in 2011, OMMAX has around 400 consultants working from offices in several European markets. The consulting firm serves corporates, mid-sized companies, and private equity firms.

“What attracted me to OMMAX was its strong position in healthcare and consumer health and its distinctive combination of deep sector expertise, strategic transformation capabilities and AI engineering,” said Welchering.

Having already built a significant client base across pharmaceuticals, consumer health, medtech and healthcare services – including more than 150 clients across over 20 markets – OMMAX aims to expand its Life Sciences & Healthcare business internationally to meet growing demand for AI-enabled commercial and operational transformation.

“The industry has now reached a fascinating inflection point,” said Welchering. “AI is fundamentally changing how healthcare companies operate, engage with customers and patients, and compete.”

“Healthcare companies do not need another list of 100 potential AI use cases,” added Konhäuser. “They need a partner that combines strategic judgment and deep sector expertise with the ability to implement AI at scale, redesign operating models and measure the resulting impact. Sandra brings an exceptional combination of hands-on industry experience, strategic judgment and commercial transformation expertise.”

The Life Sciences & Healthcare practice of OMMAX combines deep expertise in data and AI with engineering capabilities across areas including commercial excellence, customer engagement, research & development, supply chain and operational efficiency. The firm works from strategy development and concepting through to implementation and long-term value creation.